Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorWayne State University

About this trial

Opioids are often added with a local anesthetic to enhance the duration and quality of spinal anesthesia for cesarean delivery patients. However, spinal opioids are associated with a wide variety of side effects such as nausea, vomiting, (N/V) and pruritus (itching). The occurrence of pruritus can vary between 30% and 100% making pruritus the most common side-effect of intrathecal opioids and this rate is even higher in pregnant patients. Pruritus may require treatment which can be ineffective or sometimes reverse the analgesic effect of the opioids. Ondansetron is a safe and very commonly used Serotonin receptor antagonist treatment for local anesthetic opioid-induced pruritus used in pregnancy. The effect of different administration times of ondansetron in reducing pruritus or N/V in cesarean section (CS) cases has not been extensively studied and thus, this prospective study can help guide future clinical management of side effects caused by spinal intrathecal morphine administration.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists (ASA) physical status 1-3

Adult parturient (18 -50 years of age) scheduled to undergo elective cesarean delivery under spinal anesthesia

Patients must be willing and cognitively able to give written informed study consent

Disqualifiers

Patients with an ASA physiological assessment greater than grade 3

Allergies to local anesthetics, opioids, or ondansetron

Coagulopathies precluding provision of spinal anesthesia

Pre-eclampsia with severe features

Trial design

Treatments tested in this trial

  • Ondansetron 8mg

Treatment groups

66 Participants
are divided into 2 treatment groups

Sponsors and collaborators